最新消息

最新消息

禾伸堂生技參加AACR Annual Meeting 2018

13, Apr 2018

禾伸堂生技股份有限公司參加 Chicago 2018 AACR Annual Meeting (2018/4/14-4/18) poster presentation. 由 Dr. Eskouhie Tchaparian 於會議期間介紹本公司抗大腸/直腸癌新藥 CA102N

Poster Abstract Number: #7883

Subject: Evaluation of antitumor efficacy of CA102N, H-Nim and hyaluronic acid (HA) conjugate, alone or in combination with 5-fluorouracil (5-FU) in in vivo human colorectal cancer models

The American Association for Cancer Research (AACR) was founded in 1907 "to further the investigation and spread the knowledge of cancer." Today, the AACR accelerates progress toward the prevention and cure of cancer by promoting research, education, communication, and collaboration.

AACR Annual Meeting 2018相關訊息可參考:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136#.Ws8k6q6WY-c

 

上一頁